BLUF

Research suggests the shingles vaccine Shingrix may reduce heart attack, stroke, and heart failure risk by 12 percent for several years after vaccination. Potential major cardiovascular benefits for older adults if confirmed in clinical trials.

Learning Outcomes 

  • Describe the relationship between shingles vaccination and cardiovascular health, including the reported reduction in heart attack, stroke, and heart failure risk associated with the Shingrix vaccine.
  • Interpret key findings from observational health research, including understanding study design, reported risk reductions, and the importance of confirming results through randomized controlled trials.
  • Evaluate the potential public health impact of vaccination programs by assessing how shingles prevention may contribute to reducing cardiovascular disease and improving health outcomes in older adults. 
READ: Shingles vaccine linked to lower risk of heart attack and stroke, study finds

References